Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_assertion type Assertion NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_head.
- NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_assertion description "[Preoperative combination of gemcitabine, carboplatin, and iniparib is active in the treatment of early-stage triple-negative and BRCA1/2 mutation-associated breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_provenance.
- NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_assertion evidence source_evidence_literature NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_provenance.
- NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_assertion SIO_000772 25847929 NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_provenance.
- NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_assertion wasDerivedFrom befree-2016 NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_provenance.
- NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_assertion wasGeneratedBy ECO_0000203 NP1276266.RAvMWnEgqoN090BRg2kdYrzM0RuFjTz6rMUVI4-U8B_yQ130_provenance.